Maryland Senate Bill 1151 (Prior Session Legislation)

---

Spectrum: Partisan Bill (Democrat 1-0)
Status: Introduced on February 19 2018 - 25% progression, died in committee
Action: 2018-03-13 - Hearing 3/13 at 1:00 p.m.
Pending: Senate Budget and Taxation Committee
Text: Latest bill text (Introduced) [PDF]

Altering the definition of "qualified Maryland biotechnology company" to repeal certain limitations on the period of time for which a company may have been in active business for purposes of eligibility for the biotechnology tax credit; declaring the intent of the General Assembly that the credit will encourage private sector investment in Maryland biotechnology companies; altering a certain limitation on the aggregate credits that the Secretary of Commerce may certify for certain investments; applying the Act; etc.

Income Tax - Biotechnology Investment Incentive Tax Credit - Alteration

Sen. Nancy King [D]

Date	Chamber	Action
2018-03-13	Senate	Hearing 3/13 at 1:00 p.m.
2018-02-23	Senate	Rereferred to Budget and Taxation
2018-02-19	Senate	First Reading Senate Rules

Type	Source
Summary	https://mgaleg.maryland.gov/mgawebsite/Legislation/Details/SB1151?ys=2018rs
Text	https://mgaleg.maryland.gov/2018RS/bills/sb/sb1151f.pdf
Supplement	https://mgaleg.maryland.gov/2018RS/fnotes/bil_0001/sb1151.pdf